{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:32:50Z","timestamp":1789763570831,"version":"4.0.1"},"reference-count":136,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases reported\nin the aging population across the globe. About 46.8 million people are reported to have dementia,\nand AD is mainly responsible for dementia in aged people. Alzheimer's disease (AD) is thought\nto occur due to the accumulation of \u03b2-amyloid (A\u03b2) in the neocortex portion of the brain, nitric\noxide mediated dysfunctioning of blood-brain barrier, reduced activity of serine racemase enzyme,\ncell cycle disturbances, damage of N-methyl-D-aspartate (NMDA) receptors and glutamatergic neurotransmission.\nModern treatment methods target the pathways responsible for the disease. To\ndate, solely symptomatic treatments exist for this disease, all making an attempt to counterbalance\nthe neurotransmitter disturbance. Treatments able to prevent or at least effectively modifying the\ncourse of AD, referred to as \u2018disease-modifying\u2019 drugs, are still under extensive research. Effective\ntreatments entail a better indulgence of the herbal bioactives by novel drug delivery systems. The\nherbal bioactive administered by novel drug delivery systems have proved beneficial in treating\nthis disease. This review provides detailed information about the role of medicinal plants and their\nformulations in treating Alzheimer\u2019s disease which will be highly beneficial for the researchers\nworking in this area.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201818666211015152733","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T05:50:42Z","timestamp":1637041842000},"page":"212-228","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Comprehensive Review on Medicinal Herbs and Novel Formulations for\nthe Prevention of Alzheimer\u2019s Disease"],"prefix":"10.2174","volume":"19","author":[{"given":"Sarabjit","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balbir","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasandeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahmjot","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navkaran","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Rajput","sequence":"additional","affiliation":[{"name":"Department of Botanical and\nEnvironmental Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Sidhu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Botanical and\nEnvironmental Sciences, Guru Nanak Dev University, Amritsar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"10","author":"Prince M.","year":"2015","unstructured":"Prince M.; Wimo A.; Guerchet M.; Ali G.C.; Wu Y.T.; Prina M.; The global prevalence of dementia. World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends 2015,10-27","journal-title":"World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1590\/0004-282x20200010","volume":"78","author":"Sousa J.C.E.","year":"2020","unstructured":"Sousa J.C.E.; Santana A.C.F.; Magalh\u00c3es G.J.P.; Resveratrol in Alzheimer\u2019s disease: A review of pathophysiology and therapeutic potential. Arq Neuropsiquiatr 2020,78(8),501-511","journal-title":"Arq Neuropsiquiatr"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"117996","DOI":"10.1016\/j.lfs.2020.117996","volume":"256","author":"Abeysinghe A.A.D.T.","year":"2020","unstructured":"Abeysinghe A.A.D.T.; Deshapriya R.D.U.S.; Udawatte C.; Alzheimer\u2019s disease; a review of the pathophysiological basis and therapeutic interventions. Life Sci 2020,256,117996","journal-title":"Life Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","volume":"68","author":"Graham W.V.","year":"2017","unstructured":"Graham W.V.; Bonito-Oliva A.; Sakmar T.P.; Update on Alzheimer\u2019s disease therapy and prevention strategies. Annu Rev Med 2017,68,413-430","journal-title":"Annu Rev Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1017\/S1092852900014164","volume":"10","author":"Francis P.T.","year":"2005","unstructured":"Francis P.T.; The interplay of neurotransmitters in Alzheimer\u2019s disease. CNS Spectr 2005,10(11)(Suppl. 18),6-9","journal-title":"CNS Spectr"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cobeha.2020.01.013","volume":"32","author":"Decker A.L.","year":"2020","unstructured":"Decker A.L.; Duncan K.; Acetylcholine and the complex interdependence of memory and attention. Curr Opin Behav Sci 2020,32,21-28","journal-title":"Curr Opin Behav Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11033-010-0128-9","volume":"38","author":"Peng S.","year":"2011","unstructured":"Peng S.; Zhang Y.; Zhang J.; Wang H.; Ren B.; Glutamate receptors and signal transduction in learning and memory. Mol Biol Rep 2011,38(1),453-460","journal-title":"Mol Biol Rep"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JAD-190577","volume":"72","author":"Snowden S.G.","year":"2019","unstructured":"Snowden S.G.; Ebshiana A.A.; Hye A.; Pletnikova O.; O\u2019Brien R.; Yang A.; Troncoso J.; Legido-Quigley C.; Thambisetty M.; Neurotransmitter imbalance in the brain and Alzheimer\u2019s disease pathology. J Alzheimers Dis 2019,72(1),35-43","journal-title":"J Alzheimers Dis"},{"key":"ref=9","first-page":"15","author":"Nam E.","year":"2019","unstructured":"Nam E.; Nam G.; Lim M.H.; Synaptic copper, amyloid-&#x3B2;, and neurotransmitters in Alzheimer\u2019s disease. Biochem 2019,15-17","journal-title":"Biochem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","volume":"77","author":"Behl C.","year":"1994","unstructured":"Behl C.; Davis J.B.; Lesley R.; Schubert D.; Hydrogen peroxide mediates amyloid \u03b2 protein toxicity. Cell 1994,77(6),817-827","journal-title":"Cell"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/0006-291X(92)90837-B","volume":"186","author":"Behl C.","year":"1992","unstructured":"Behl C.; Davis J.; Cole G.M.; Schubert D.; Vitamin E protects nerve cells from amyloid \u03b2 protein toxicity. Biochem Biophys Res Commun 1992,186(2),944-950","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1471-4159.1990.tb08858.x","volume":"55","author":"Subbarao K.V.","year":"1990","unstructured":"Subbarao K.V.; Richardson J.S.; Ang L.C.; Autopsy samples of Alzheimer\u2019s cortex show increased peroxidation in vitro.\n J Neurochem 1990,55(1),342-345","journal-title":"J Neurochem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2009.11.033","volume":"469","author":"Padurariu M.","year":"2010","unstructured":"Padurariu M.; Ciobica A.; Hritcu L.; Stoica B.; Bild W.; Stefanescu C.; Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurosci Lett 2010,469(1),6-10","journal-title":"Neurosci Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10571-015-0157-y","volume":"35","author":"Ferreira M.E.S.","year":"2015","unstructured":"Ferreira M.E.S.; de Vasconcelos A.S.; da Costa Vilhena T.; da Silva T.L.; da Silva Barbosa A.; Gomes A.R.Q.; Dolabela M.F.; Perc\u00e1rio S.; Oxidative stress in Alzheimer\u2019s disease: should we keep trying antioxidant therapies? Cell Mol Neurobiol 2015,35(5),595-614","journal-title":"Cell Mol Neurobiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"549772","DOI":"10.3389\/fnins.2020.549772","volume":"14","author":"Yu C.C.","year":"2020","unstructured":"Yu C.C.; Du Y.J.; Wang S.Q.; Liu L.B.; Shen F.; Wang L.; Lin Y.F.; Kong L.H.; Experimental evidence of the benefits of acupuncture for Alzheimer\u2019s disease: an updated review. Front Neurosci 2020,14,549772","journal-title":"Front Neurosci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.4103\/1673-5374.205108","volume":"12","author":"Akram M.","year":"2017","unstructured":"Akram M.; Nawaz A.; Effects of medicinal plants on Alzheimer\u2019s disease and memory deficits. Neural Regen Res 2017,12(4),660-670","journal-title":"Neural Regen Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/ggi.13488","volume":"18","author":"Li X.","year":"2018","unstructured":"Li X.; Sundquist J.; Z\u00f6ller B.; Sundquist K.; Dementia and Alzheimer\u2019s disease risks in patients with autoimmune disorders. Geriatr Gerontol Int 2018,18(9),1350-1355","journal-title":"Geriatr Gerontol Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuro.2017.03.006","volume":"61","author":"Hersi M.","year":"2017","unstructured":"Hersi M.; Irvine B.; Gupta P.; Gomes J.; Birkett N.; Krewski D.; Risk factors associated with the onset and progression of Alzheimer\u2019s disease: a systematic review of the evidence. Neurotoxicol 2017,61,143-187","journal-title":"Neurotoxicol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/joim.12178","volume":"275","author":"Solomon A.","year":"2014","unstructured":"Solomon A.; Mangialasche F.; Richard E.; Andrieu S.; Bennett D.A.; Breteler M.; Fratiglioni L.; Hooshmand B.; Khachaturian A.S.; Schneider L.S.; Skoog I.; Kivipelto M.; Advances in the prevention of Alzheimer\u2019s disease and dementia. J Intern Med 2014,275(3),229-250","journal-title":"J Intern Med"},{"key":"ref=20a","doi-asserted-by":"publisher","first-page":"207178","DOI":"10.1155\/2013\/207178","volume":"2013","author":"Defina P.A.","year":"2013","unstructured":"Defina P.A.; Moser R.S.; Glenn M.; Lichtenstein J.D.; Fellus J.; Alzheimer\u2019s disease clinical and research update for health care practitioners. J Aging Res 2013,2013,207178","journal-title":"J Aging Res"},{"key":"ref=20b","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"Serrano-Pozo A.","year":"2021","unstructured":"Serrano-Pozo A.; Das S.; Hyman B.T.; APOE and Alzheimer\u2019s disease: Advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 2021,20(1),68-80","journal-title":"Lancet Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"Mattson M.P.","year":"2004","unstructured":"Mattson M.P.; Pathways towards and away from Alzheimer\u2019s disease. Nature 2004,430(7000),631-639","journal-title":"Nature"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"Wang J.","year":"2017","unstructured":"Wang J.; Gu B.J.; Masters C.L.; Wang Y.J.; A systemic view of Alzheimer disease - insights from amyloid-&#x3B2; metabolism beyond the brain. Nat Rev Neurol 2017,13(10),612-623","journal-title":"Nat Rev Neurol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(92)90003-K","volume":"46","author":"Lassmann H.","year":"1992","unstructured":"Lassmann H.; Weiler R.; Fischer P.; Bancher C.; Jellinger K.; Floor E.; Danielczyk W.; Seitelberger F.; Winkler H.; Synaptic pathology in Alzheimer\u2019s disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 1992,46(1),1-8","journal-title":"Neuroscience"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"Kumar A.","year":"2015","unstructured":"Kumar A.; Singh A.; Ekavali ; A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 2015,67(2),195-203","journal-title":"Pharmacol Rep"},{"key":"ref=25","first-page":"1","author":"Fernandez M.A.","year":"2015","unstructured":"Fernandez M.A.; Sequential proteolysis by \u03b3 -secretase and its implications for. Alzheimer\u2019s Dis 2015,1-178","journal-title":"Alzheimer\u2019s Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/acel.12054","volume":"12","author":"Alberdi E.","year":"2013","unstructured":"Alberdi E.; Wyssenbach A.; Alberdi M.; S\u00e1nchez-G\u00f3mez M.V.; Cavaliere F.; Rodr\u00edguez J.J.; Verkhratsky A.; Matute C.; Ca(dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid \u03b2-treated astrocytes and in a model of Alzheimer\u2019s disease. Aging Cell 2013,12(2),292-302","journal-title":"Aging Cell"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ejmech.2016.07.054","volume":"124","author":"Kumar V.","year":"2016","unstructured":"Kumar V.; Sami N.; Kashav T.; Islam A.; Ahmad F.; Hassan M.I.; Protein aggregation and neurodegenerative diseases: From theory to therapy. Eur J Med Chem 2016,124,1105-1120","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e927739","DOI":"10.12659\/MSM.927739","volume":"26","author":"Stefano G.B.","year":"2020","unstructured":"Stefano G.B.; Esch T.; Ptacek R.; Kream R.M.; Dysregulation of nitric oxide signaling in microglia: multiple points of functional convergence in the complex pathophysiology of Alzheimer Disease. Med Sci Monit 2020,26,e927739","journal-title":"Med Sci Monit"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12035-018-1092-y","volume":"56","author":"Morris G.","year":"2019","unstructured":"Morris G.; Berk M.; Maes M.; Puri B.K.; Could Alzheimer\u2019s disease originate in the periphery and if so how so? Mol Neurobiol 2019,56(1),406-434","journal-title":"Mol Neurobiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00281-015-0518-0","volume":"37","author":"Gold M.","year":"2015","unstructured":"Gold M.; El Khoury J.; \u03b2-amyloid, microglia, and the inflammasome in Alzheimer\u2019s disease. Semin Immunopathol 2015,37(6),607-611","journal-title":"Semin Immunopathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnins.2019.00043","volume":"13","author":"Liu J.","year":"2019","unstructured":"Liu J.; Chang L.; Song Y.; Li H.; Wu Y.; The role of NMDA receptors in Alzheimer\u2019s disease. Front Neurosci 2019,13,43","journal-title":"Front Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/00003495-200161010-00005","volume":"61","author":"Grutzendler J.","year":"2001","unstructured":"Grutzendler J.; Morris J.C.; Cholinesterase inhibitors for Alzheimer\u2019s disease. Drugs 2001,61(1),41-52","journal-title":"Drugs"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.pnpbp.2003.11.009","volume":"28","author":"Hashimoto K.","year":"2004","unstructured":"Hashimoto K.; Fukushima T.; Shimizu E.; Okada S.; Komatsu N.; Okamura N.; Koike K.; Koizumi H.; Kumakiri C.; Imai K.; Iyo M.; Possible role of D-serine in the pathophysiology of Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 2004,28(2),385-388","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"Xu W.","year":"2017","unstructured":"Xu W.; Xu Q.; Cheng H.; Tan X.; The efficacy and pharmacological mechanism of Zn 7 MT3 to protect against Alzheimer\u2019s disease. Sci Rep 2017,7(1),1-5","journal-title":"Sci Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/1568007054546117","volume":"4","author":"Pereira C.","year":"2005","unstructured":"Pereira C.; Agostinho P.; Moreira P.I.; Cardoso S.M.; Oliveira C.R.; Alzheimer\u2019s disease-associated neurotoxic mechanisms and neuroprotective strategies. Curr Drug Targets CNS Neurol Disord 2005,4(4),383-403","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","volume":"33","author":"Wang J.Z.","year":"2013","unstructured":"Wang J.Z.; Xia Y.Y.; Grundke-Iqbal I.; Iqbal K.; Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 2013,33(s1)(Suppl. 1),S123-S139","journal-title":"J Alzheimers Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuropharm.2010.02.010","volume":"59","author":"Francis P.T.","year":"2010","unstructured":"Francis P.T.; Ram\u00edrez M.J.; Lai M.K.; Neurochemical basis for symptomatic treatment of Alzheimer\u2019s disease. Neuropharmacology 2010,59(4-5),221-229","journal-title":"Neuropharmacology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrd2314","volume":"6","author":"Melnikova I.","year":"2007","unstructured":"Melnikova I.; Therapies for Alzheimer\u2019s disease. Nat Rev Drug Discov 2007,6(5),341-342","journal-title":"Nat Rev Drug Discov"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3928\/00989134-20100330-08","volume":"36","author":"Kristensson J.","year":"2010","unstructured":"Kristensson J.; Hallberg I.R.; Ekwall A.K.; Frail older adult\u2019s experiences of receiving health care and social services. J Gerontol Nurs 2010,36(10),20-28","journal-title":"J Gerontol Nurs"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","volume":"68","author":"Gody\u0144 J.","year":"2016","unstructured":"Gody\u0144 J.; Jo\u0144czyk J.; Panek D.; Malawska B.; Therapeutic strategies for Alzheimer\u2019s disease in clinical trials. Pharmacol Rep 2016,68(1),127-138","journal-title":"Pharmacol Rep"},{"key":"ref=41","first-page":"2012","author":"Mehta M.","year":"2012","unstructured":"Mehta M.; Adem A.; Sabbagh M.; New acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Int J Alz Dis 2012,2012","journal-title":"Int J Alz Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2016.04.013","volume":"327","author":"Santos M.A.","year":"2016","unstructured":"Santos M.A.; Chand K.; Chaves S.; Recent progress in multifunctional metal chelators as potential drugs for Alzheimer\u2019s disease. Coord Chem Rev 2016,327,287-303","journal-title":"Coord Chem Rev"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2165\/00002512-200724110-00001","volume":"24","author":"Seltzer B.","year":"2007","unstructured":"Seltzer B.; Is long-term treatment of Alzheimer\u2019s disease with cholinesterase inhibitor therapy justified? Drugs Aging 2007,24(11),881-890","journal-title":"Drugs Aging"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/2231-0738.95927","volume":"2","author":"Singhal A.K.","year":"2012","unstructured":"Singhal A.K.; Naithani V.; Bangar O.P.; Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int J Nutr Pharmacol Neurol Dis 2012,2(2),84","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"key":"ref=45","first-page":"454","volume":"5","author":"Hassan M.A.","year":"2014","unstructured":"Hassan M.A.; Balasubramanian R.; Masoud A.D.; Burkan Z.E.; Sughir A.; Kumar R.S.; Role of medicinal plants in neurodegenerative diseases with special emphasis to Alzheimer\u2019s. Int J Phytopharmacol 2014,5(6),454-462","journal-title":"Int J Phytopharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/ijms11010107","volume":"11","author":"Shi C.","year":"2010","unstructured":"Shi C.; Liu J.; Wu F.; Yew D.T.; \nGinkgo biloba extract in Alzheimer\u2019s disease: from action mechanisms to medical practice. Int J Mol Sci 2010,11(1),107-123","journal-title":"Int J Mol Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/cam.3.1.7402","volume":"3","author":"Gella A.","year":"2009","unstructured":"Gella A.; Durany N.; Oxidative stress in Alzheimer disease. Cell Adhes Migr 2009,3(1),88-93","journal-title":"Cell Adhes Migr"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"13102","DOI":"10.1523\/JNEUROSCI.3448-06.2006","volume":"26","author":"Wu Y.","year":"2006","unstructured":"Wu Y.; Wu Z.; Butko P.; Christen Y.; Lambert M.P.; Klein W.L.; Link C.D.; Luo Y.; Amyloid-&#x3B2;-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 2006,26(50),13102-13113","journal-title":"J Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-0-387-46401-5_1","volume":"595","author":"Aggarwal B.B.","year":"2007","unstructured":"Aggarwal B.B.; Sundaram C.; Malani N.; Ichikawa H.; Curcumin: the Indian solid gold. Adv Exp Med Biol 2007,595,1-75","journal-title":"Adv Exp Med Biol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JAD-170188","volume":"58","author":"Tang M.","year":"2017","unstructured":"Tang M.; Taghibiglou C.; The mechanisms of action of curcumin in Alzheimer\u2019s disease. J Alzheimers Dis 2017,58(4),1003-1016","journal-title":"J Alzheimers Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s12035-016-9802-9","volume":"54","author":"Zheng K.","year":"2017","unstructured":"Zheng K.; Dai X.; Xiao N.; Wu X.; Wei Z.; Fang W.; Zhu Y.; Zhang J.; Chen X.; Curcumin ameliorates memory decline via inhibiting BACE1 expression and \u03b2-Amyloid pathology in 5\u00d7 FAD transgenic mice. Mol Neurobiol 2017,54(3),1967-1977","journal-title":"Mol Neurobiol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","volume":"32","author":"Jope R.S.","year":"2007","unstructured":"Jope R.S.; Yuskaitis C.J.; Beurel E.; Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 2007,32(4-5),577-595","journal-title":"Neurochem Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/acs.jmedchem.5b00894","volume":"59","author":"Di Martino R.M.","year":"2016","unstructured":"Di Martino R.M.; De Simone A.; Andrisano V.; Bisignano P.; Bisi A.; Gobbi S.; Rampa A.; Fato R.; Bergamini C.; Perez D.I.; Martinez A.; Bottegoni G.; Cavalli A.; Belluti F.; Versatility of the curcumin scaffold: discovery of potent and balanced dual BACE-1 and GSK-3\u03b2 inhibitors. J Med Chem 2016,59(2),531-544","journal-title":"J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cyto.2017.10.019","volume":"102","author":"Pandey A.","year":"2018","unstructured":"Pandey A.; Bani S.; Dutt P.; Kumar Satti N.; Avtar Suri K.; Nabi Qazi G.; Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine 2018,102,211-221","journal-title":"Cytokine"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"112876","DOI":"10.1016\/j.jep.2020.112876","volume":"257","author":"Zahiruddin S.","year":"2020","unstructured":"Zahiruddin S.; Basist P.; Parveen A.; Parveen R.; Khan W.; Gaurav ; Ahmad S.; Ashwagandha in brain disorders: A review of recent developments. J Ethnopharmacol 2020,257,112876","journal-title":"J Ethnopharmacol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"Sehgal N.","year":"2012","unstructured":"Sehgal N.; Gupta A.; Valli R.K.; Joshi S.D.; Mills J.T.; Hamel E.; Khanna P.; Jain S.C.; Thakur S.S.; Ravindranath V.; \nWithania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA 2012,109(9),3510-3515","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","volume":"113","author":"Ma X.","year":"2007","unstructured":"Ma X.; Tan C.; Zhu D.; Gang D.R.; Xiao P.; Huperzine A.; Huperzine A from Huperzia species-an ethnopharmacolgical review. J Ethnopharmacol 2007,113(1),15-34","journal-title":"J Ethnopharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.tjog.2011.04.004","volume":"50","author":"Wu T.Y.","year":"2011","unstructured":"Wu T.Y.; Chen C.P.; Jinn T.R.; Traditional Chinese medicines and Alzheimer\u2019s disease. Taiwan J Obstet Gynecol 2011,50(2),131-135","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref=59","first-page":"1e26","volume":"27","author":"Wang R.","year":"2006","unstructured":"Wang R.; Yan H.; Tang X.C.; Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin 2006,27,1e26","journal-title":"Acta Pharmacol Sin"},{"key":"ref=60","first-page":"4258","volume":"7","author":"Yang C.Y.","year":"2003","unstructured":"Yang C.Y.; Lu Z.P.; Zheng C.G.; Efficacy and reliability of huperzine A in mild and moderate Alzheimer\u2019s disease. Zhongguo Linchuang Kangfu 2003,7,4258-4259","journal-title":"Zhongguo Linchuang Kangfu"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1080\/09168451.2015.1052773","volume":"79","author":"Ohba T.","year":"2015","unstructured":"Ohba T.; Yoshino Y.; Ishisaka M.; Abe N.; Tsuruma K.; Shimazawa M.; Oyama M.; Tabira T.; Hara H.; Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice. Biosci Biotechnol Biochem 2015,79(11),1838-1844","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/act.2007.13603","volume":"13","author":"Duke J.A.","year":"2007","unstructured":"Duke J.A.; The Garden Pharmacy: Rosemary, the herb of remembrance for Alzheimer\u2019s disease. Altern Complement Ther 2007,13(6),287-290","journal-title":"Altern Complement Ther"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/2231-0738.95927","volume":"2","author":"Singhal A.K.","year":"2012","unstructured":"Singhal A.K.; Naithani V.; Bangar O.P.; Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int J Nutr Pharmacol 2012,2(2),84","journal-title":"Int J Nutr Pharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40268-016-0157-5","volume":"17","author":"Lopresti A.L.","year":"2017","unstructured":"Lopresti A.L.; Salvia (sage): A review of its potential cognitive-enhancing and protective effects. Drugs R D 2017,17(1),53-64","journal-title":"Drugs R D"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fnsyn.2014.00024","volume":"6","author":"Luchicchi A.","year":"2014","unstructured":"Luchicchi A.; Bloem B.; Via\u00f1a J.N.; Mansvelder H.D.; Role L.W.; Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors. Front Synaptic Neurosci 2014,6,24","journal-title":"Front Synaptic Neurosci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pharma.2015.03.005","volume":"73","author":"Smach M.A.","year":"2015","unstructured":"Smach M.A.; Hafsa J.; Charfeddine B.; Dridi H.; Limem K.; Effects of sage extract on memory performance in mice and acetylcholinesterase activity. Ann Pharm Fr 2015,73(4),281-288","journal-title":"Ann Pharm Fr"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5530\/pj.2020.12.20","volume":"12","author":"Sanjana D.","year":"2020","unstructured":"Sanjana D.; Shailendra P.; Evaluation of traditional herb extract Salvia officinalis in treatment of Alzheimer\u2019s disease. Pharmacogn J 2020,12(1),131-143","journal-title":"Pharmacogn J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"236186","DOI":"10.1093\/ecam\/neq038","volume":"2011","author":"Saraf M.K.","year":"2011","unstructured":"Saraf M.K.; Prabhakar S.; Khanduja K.L.; Anand A.; \nBacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice. Evid Based Complement Alternat Med 2011,2011,236186","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4103\/0974-8520.92549","volume":"32","author":"Mukherjee S.","year":"2011","unstructured":"Mukherjee S.; Dugad S.; Bhandare R.; Pawar N.; Jagtap S.; Pawar P.K.; Kulkarni O.; Evaluation of comparative free-radical quenching potential of Brahmi (Bacopa monnieri) and Mandookparni (Centella asiatica). Ayu 2011,32(2),258-264","journal-title":"Ayu"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0031-9422(01)00275-8","volume":"58","author":"Chakravarty A.K.","year":"2001","unstructured":"Chakravarty A.K.; Sarkar T.; Masuda K.; Shiojima K.; Nakane T.; Kawahara N.; Bacopaside I and II: two pseudojujubogenin glycosides from Bacopa monniera.\n Phytochemistry 2001,58(4),553-556","journal-title":"Phytochemistry"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jep.2008.07.039","volume":"120","author":"Limpeanchob N.","year":"2008","unstructured":"Limpeanchob N.; Jaipan S.; Rattanakaruna S.; Phrompittayarat W.; Ingkaninan K.; Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol 2008,120(1),112-117","journal-title":"J Ethnopharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3233\/JAD-2006-9303","volume":"9","author":"Holcomb L.A.","year":"2006","unstructured":"Holcomb L.A.; Dhanasekaran M.; Hitt A.R.; Young K.A.; Riggs M.; Manyam B.V.; \nBacopa monniera extract reduces amyloid levels in PSAPP mice. J Alzheimers Dis 2006,9(3),243-251","journal-title":"J Alzheimers Dis"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1177392819866412","DOI":"10.1177\/1177392819866412","volume":"13","author":"Abdul Manap A.S.","year":"2019","unstructured":"Abdul Manap A.S.; Vijayabalan S.; Madhavan P.; Chia Y.Y.; Arya A.; Wong E.H.; Rizwan F.; Bindal U.; Koshy S.; \nBacopa monnieri, a neuroprotective lead in Alzheimer Disease: A review on its properties, mechanisms of action, and preclinical and clinical studies. Drug Target Insights 2019,13,1177392819866412","journal-title":"Drug Target Insights"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"945217","DOI":"10.1155\/2015\/945217","volume":"2015","author":"Rajan K.E.","year":"2015","unstructured":"Rajan K.E.; Preethi J.; Singh H.K.; Molecular and functional characterization of Bacopa monniera: A retrospective review. Evid Based Complement Alternat Med 2015,2015,945217","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"780","DOI":"10.12980\/APJTB.4.2014APJTB-2014-0412","volume":"4","author":"Jivad N.","year":"2014","unstructured":"Jivad N.; Rabiei Z.; A review study on medicinal plants used in the treatment of learning and memory impairments. Asian Pac J Trop Biomed 2014,4(10),780-789","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.fct.2007.04.002","volume":"45","author":"Rubio J.","year":"2007","unstructured":"Rubio J.; Dang H.; Gong M.; Liu X.; Chen S.L.; Gonzales G.F.; Aqueous and hydroalcoholic extracts of Black Maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice. Food Chem Toxicol 2007,45(10),1882-1890","journal-title":"Food Chem Toxicol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/ptr.5449","volume":"29","author":"Park S.J.","year":"2015","unstructured":"Park S.J.; Ahn Y.J.; Lee H.E.; Hong E.; Ryu J.H.; Standardized Prunella vulgaris var.lilacina extract enhances cognitive performance in normal naive mice. Phytother Res 2015,29(11),1814-1821","journal-title":"Phytother Res"},{"key":"ref=78","first-page":"584","volume":"115","author":"Robu S.","year":"2011","unstructured":"Robu S.; Aprotosoaie A.C.; Spac A.; Cioanc\u0103 O.; H\u0103ncianu M.; St\u0103nescu U.; Studies regarding chemical composition of lavender volatile oils. Revista medico-chirurgicala a Societatii de Medicisi Naturalisti din Iasi 2011,115(2),584-589","journal-title":"Revista medico-chirurgicala a Societatii de Medicisi Naturalisti din Iasi"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"7426538","DOI":"10.1155\/2017\/7426538","volume":"2017","author":"Xu P.","year":"2017","unstructured":"Xu P.; Wang K.; Lu C.; Dong L.; Gao L.; Yan M.; Aibai S.; Yang Y.; Liu X.; The Protective effect of lavender essential oil and its main component linalool against the cognitive deficits induced by d-galactose and aluminum trichloride in mice. Evid Based Complement Alternat Med 2017,2017,7426538","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biomag.2013.08.006","volume":"3","author":"Zahra R.","year":"2013","unstructured":"Zahra R.; Mohammadreza H.; Mahmoud R.K.; Zahra A.; Effect of Cyperus rotundus tubers ethanolic extract on learning and memory in animal model of Alzheimer. Biomed Aging Pathol 2013,3,185-191","journal-title":"Biomed Aging Pathol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5958\/2231-5659.2019.00017.1","volume":"9","author":"Jadhav R.P.","year":"2019","unstructured":"Jadhav R.P.; Kengar M.D.; Narule O.V.; Koli V.W.; Kumbhar S.B.; A review on Alzheimer\u2019s Disease (AD) and its herbal treatment of Alzheimer\u2019s Disease. Asian J Res Pharmac Sci 2019,9(2),112-122","journal-title":"Asian J Res Pharmac Sci"},{"key":"ref=82","first-page":"574","volume":"1","author":"Kirtikar K.R.","year":"1944","unstructured":"Kirtikar K.R.; Basu B.D.;  1944,1,574-577"},{"key":"ref=83","first-page":"1","volume":"9","author":"Singh N.","year":"1974","unstructured":"Singh N.; Chand N.; Kohli R.P.; Pharmacological studies on Celastruspaniculata (Malkangni). J Res Indian Med 1974,9,1-8","journal-title":"J Res Indian Med"},{"key":"ref=84","first-page":"130","volume":"2","author":"George L.","year":"2010","unstructured":"George L.; Kumar B.P.; Rao S.N.; Arockiasamy I.; Karthik M.; Cognitive enhancement and Neuroprotective effect of Celastruspaniculatus Willd. seed oil (Jyothismati oil) on male wistar rats. J Pharm Sci Technol 2010,2(2),130-138","journal-title":"J Pharm Sci Technol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000085382","volume":"14","author":"Houghton P.J.","year":"2005","unstructured":"Houghton P.J.; Howes M.J.; Natural products and derivatives affecting neurotransmission relevant to Alzheimer\u2019s and Parkinson\u2019s disease. Neurosignals 2005,14(1-2),6-22","journal-title":"Neurosignals"},{"key":"ref=86","first-page":"107","volume":"9","author":"Soodi M.","year":"2014","unstructured":"Soodi M.; Naghdi N.; Hajimehdipoor H.; Choopani S.; Sahraei E.; Memory-improving activity of Melissa officinalis extract in na\u00efve and scopolamine-treated rats. Res Pharm Sci 2014,9(2),107-114","journal-title":"Res Pharm Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"9729818","DOI":"10.1155\/2016\/9729818","volume":"2016","author":"Ozarowski M.","year":"2016","unstructured":"Ozarowski M.; Mikolajczak P.L.; Piasecka A.; Kachlicki P.; Kujawski R.; Bogacz A.; Czerny B.; Influence of the Melissa officinalis leaf extract on long-term memory in scopolamine animal model with assessment of mechanism of action. Evid Based Complement Alternat Med 2016,2016,9729818","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ptr.2922","volume":"24","author":"Muralidharan P.","year":"2010","unstructured":"Muralidharan P.; Kumar V.R.; Balamurugan G.; Protective effect of Morinda citrifolia fruits on \u03b2-amyloid (25-35) induced cognitive dysfunction in mice: An experimental and biochemical study. Phytother Res 2010,24(2),252-258","journal-title":"Phytother Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jep.2011.09.057","volume":"139","author":"Pachauri S.D.","year":"2012","unstructured":"Pachauri S.D.; Tota S.; Khandelwal K.; Verma P.R.; Nath C.; Hanif K.; Shukla R.; Saxena J.K.; Dwivedi A.K.; Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: A behavioral, biochemical and cerebral blood flow study. J Ethnopharmacol 2012,139(1),34-41","journal-title":"J Ethnopharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/13880209.2020.1758732","volume":"58","author":"Deng X.","year":"2020","unstructured":"Deng X.; Zhao S.; Liu X.; Han L.; Wang R.; Hao H.; Jiao Y.; Han S.; Bai C.; \nPolygala tenuifolia: A source for anti-Alzheimer\u2019s disease drugs. Pharm Biol 2020,58(1),410-416","journal-title":"Pharm Biol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00299-013-1554-7","volume":"33","author":"Jin M.L.","year":"2014","unstructured":"Jin M.L.; Lee D.Y.; Um Y.; Lee J.H.; Park C.G.; Jetter R.; Kim O.T.; Isolation and characterization of an oxidosqualene cyclase gene encoding a \u03b2-amyrin synthase involved in Polygala tenuifolia Willd. saponin biosynthesis. Plant Cell Rep 2014,33(3),511-519","journal-title":"Plant Cell Rep"},{"key":"ref=92","first-page":"2381","volume":"47","author":"Zhang T.Z.","year":"2016","unstructured":"Zhang T.Z.; Rong W.W.; Li Q.; Bi K.S.; Research progress on Polygalae Radix.\n Chin Tradit Herbal Drugs 2016,47,2381-2389","journal-title":"Chin Tradit Herbal Drugs"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11064-013-1232-8","volume":"39","author":"Rabiei Z.","year":"2014","unstructured":"Rabiei Z.; Rafieian-Kopaei M.; Heidarian E.; Saghaei E.; Mokhtari S.; Effects of Zizyphus jujube extract on memory and learning impairment induced by bilateral electric lesions of the nucleus Basalis of Meynert in rat. Neurochem Res 2014,39(2),353-360","journal-title":"Neurochem Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.biopha.2017.05.022","volume":"91","author":"Cao Z.","year":"2017","unstructured":"Cao Z.; Wang F.; Xiu C.; Zhang J.; Li Y.; \nHypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer\u2019s disease rats. Biomed Pharmacother 2017,91,931-937","journal-title":"Biomed Pharmacother"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JAD-2003-5404","volume":"5","author":"Smith J.V.","year":"2003","unstructured":"Smith J.V.; Luo Y.; Elevation of oxidative free radicals in Alzheimer\u2019s disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 2003,5(4),287-300","journal-title":"J Alzheimers Dis"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbadis.2011.09.004","volume":"1822","author":"Mancuso C.","year":"2012","unstructured":"Mancuso C.; Siciliano R.; Barone E.; Preziosi P.; Natural substances and Alzheimer\u2019s disease: from preclinical studies to evidence based medicine. Biochim Biophys Acta 2012,1822(5),616-624","journal-title":"Biochim Biophys Acta"},{"key":"ref=97","first-page":"12","volume":"6","author":"Mahmoodi G.","year":"2019","unstructured":"Mahmoodi G.; Amini S.; The effect of Salvia officinalis hydroalcoholic extract on scopolamine-induced memory impairment in adult male mice. J Basic Res Med Sci 2019,6(1),12-20","journal-title":"J Basic Res Med Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jep.2009.09.056","volume":"127","author":"Uabundit N.","year":"2010","unstructured":"Uabundit N.; Wattanathorn J.; Mucimapura S.; Ingkaninan K.; Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer\u2019s disease model. J Ethnopharmacol 2010,127(1),26-31","journal-title":"J Ethnopharmacol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1021\/acs.jafc.6b04597","volume":"65","author":"Qu Z.","year":"2017","unstructured":"Qu Z.; Zhang J.; Yang H.; Gao J.; Chen H.; Liu C.; Gao W.; \nPrunella vulgaris L., an edible and medicinal plant, attenuates scopolamine-induced memory impairment in rats. J Agric Food Chem 2017,65(2),291-300","journal-title":"J Agric Food Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.31686\/ijier.vol8.iss12.2863","volume":"8","author":"Nedel S.S.","year":"2020","unstructured":"Nedel S.S.; Branco J.; Boeck C.R.; Ourique A.F.; Lavender as treatment of Alzheimer\u2019s disease. Int J Innov Educ Res 2020,8,12","journal-title":"Int J Innov Educ Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.phymed.2012.02.002","volume":"19","author":"Hritcu L.","year":"2012","unstructured":"Hritcu L.; Cioanca O.; Hancianu M.; Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 2012,19(6),529-534","journal-title":"Phytomedicine"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0091-3057(96)00391-7","volume":"57","author":"Gattu M.","year":"1997","unstructured":"Gattu M.; Boss K.L.; Terry A.V.; Buccafusco J.J.; Reversal of scopolamine-induced deficits in navigational memory performance by the seed oil of Celastrus paniculatus. Pharmacol Biochem Behav 1997,57(4),793-799","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/aps.2016.17","volume":"37","author":"Zhou H.","year":"2016","unstructured":"Zhou H.; Xue W.; Chu S.F.; Wang Z.Z.; Li C.J.; Jiang Y.N.; Luo L.M.; Luo P.; Li G.; Zhang D.M.; Chen N.H.; Polygalasaponin XXXII, a triterpenoid saponin from Polygalae Radix, attenuates scopolamine-induced cognitive impairments in mice. Acta Pharmacol Sin 2016,37(8),1045-1053","journal-title":"Acta Pharmacol Sin"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3892\/mmr.2015.4652","volume":"13","author":"Pi T.","year":"2016","unstructured":"Pi T.; Zhou X.W.; Cai L.; Zhang W.; Su C.F.; Wu W.T.; Ren X.M.; Luo H.M.; PI3K\/Akt signaling pathway is involved in the neurotrophic effect of senegenin. Mol Med Rep 2016,13(2),1257-1262","journal-title":"Mol Med Rep"},{"key":"ref=105","first-page":"327","volume":"35","author":"Chen Q.","year":"2015","unstructured":"Chen Q.; Chen Y.Q.; Ye H.Y.; Yu J.Q.; Shi Q.Q.; Huang Y.; The mechanism of tenuigenin for eliminating waste product accumulation in cerebral neurons of Alzheimer\u2019s disease rats via ubiquitin-proteasome pathway. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 2015,35(3),327-332","journal-title":"Chung Kuo Chung Hsi I Chieh Ho Tsa Chih"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.phymed.2015.12.009","volume":"23","author":"Guo C.","year":"2016","unstructured":"Guo C.; Shen J.; Meng Z.; Yang X.; Li F.; Neuroprotective effects of polygalacic acid on scopolamine-induced memory deficits in mice. Phytomedicine 2016,23(2),149-155","journal-title":"Phytomedicine"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pbb.2014.11.010","volume":"128","author":"Liu Y.M.","year":"2015","unstructured":"Liu Y.M.; Li Z.Y.; Hu H.; Xu S.P.; Chang Q.; Liao Y.H.; Pan R.L.; Liu X.M.; Tenuifolin, a secondary saponin from hydrolysates of polygalasaponins, counteracts the neurotoxicity induced by A\u03b225-35 peptides in vitro and in vivo. Pharmacol Biochem Behav 2015,128,14-22","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.pbb.2003.09.014","volume":"76","author":"El-Sherbiny D.A.","year":"2003","unstructured":"El-Sherbiny D.A.; Khalifa A.E.; Attia A.S.; Eldenshary Eel-D.; \nHypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 2003,76(3-4),525-533","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=109","first-page":"108","volume":"1","author":"Singh A.K.","year":"2010","unstructured":"Singh A.K.; Gupta A.; Mishra A.K.; Gupta V.; Bansal P.; Kumar S.; Medicinal plant for curing Alzheimer\u2019s disease. Int J Pharm Biol Arch 2010,1(2),108-114","journal-title":"Int J Pharm Biol Arch"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4314\/ajtcam.v10i5.2","volume":"10","author":"Sofowora A.","year":"2013","unstructured":"Sofowora A.; Ogunbodede E.; Onayade A.; The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 2013,10(5),210-229","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref=111","first-page":"216","volume":"66","author":"Bhattacharya S.K.","year":"1995","unstructured":"Bhattacharya S.K.; Kumar A.; Jaiswal A.K.; Effect of Mentat\u00ae, a herbal formulation, on experimental models of Alzheimer\u2019s disease and central cholinergic markers in rats. Fitoter 1995,66(3),216-222","journal-title":"Fitoter"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/brainsci10120964","volume":"10","author":"Mehla J.","year":"2020","unstructured":"Mehla J.; Gupta P.; Pahuja M.; Diwan D.; Diksha D.; Indian medicinal herbs and formulations for Alzheimer\u2019s disease, from traditional knowledge to scientific assessment. Brain Sci 2020,10(12),964","journal-title":"Brain Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/acm.1997.3.327","volume":"3","author":"Bhattacharya S.K.","year":"1997","unstructured":"Bhattacharya S.K.; Kumar A.; Effect of Trasina, an ayurvedic herbal formulation, on experimental models of Alzheimer\u2019s disease and central cholinergic markers in rats. J Altern Complement Med 1997,3(4),327-336","journal-title":"J Altern Complement Med"},{"key":"ref=114","first-page":"240","volume":"40","author":"Andrade C.","year":"1998","unstructured":"Andrade C.; Gowda S.; Chaturvedi S.K.; Treatment of age-related cognitive decline with a herbal formulation : A double-blind study. Indian J Psychiatry 1998,40(3),240-246","journal-title":"Indian J Psychiatry"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00124509-199806000-00004","volume":"14","author":"Vinekar A.S.","year":"1998","unstructured":"Vinekar A.S.; Andrade C.; Sriprada V.T.; George J.; Joseph T.; Chandra J.S.; Attenuation of ECS-induced retrograde amnesia by using an herbal formulation. J ECT 1998,14(2),83-88","journal-title":"J ECT"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/0974-8520.153755","volume":"35","author":"Yadav K.D.","year":"2014","unstructured":"Yadav K.D.; Reddy K.R.; Kumar V.; Beneficial effect of Brahmi Ghrita on learning and memory in normal rat. Ayu 2014,35(3),325-329","journal-title":"Ayu"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1248\/jhs.53.43","volume":"53","author":"Parle M.","year":"2007","unstructured":"Parle M.; Vasudevan M.; Memory enhancing activity of Abana\u00ae: An Indian ayurvedic poly-herbal formulation. J Health Sci 2007,53(1),43-52","journal-title":"J Health Sci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","volume":"80","author":"Mourtas S.","year":"2014","unstructured":"Mourtas S.; Lazar A.N.; Markoutsa E.; Duyckaerts C.; Antimisiaris S.G.; Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur J Med Chem 2014,80,175-183","journal-title":"Eur J Med Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/IJN.S151474","volume":"13","author":"Meng Q.","year":"2018","unstructured":"Meng Q.; Wang A.; Hua H.; Jiang Y.; Wang Y.; Mu H.; Wu Z.; Sun K.; Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease. Int J Nanomed 2018,13,705-718","journal-title":"Int J Nanomed"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijpharm.2017.07.080","volume":"530","author":"Lohan S.","year":"2017","unstructured":"Lohan S.; Raza K.; Mehta S.K.; Bhatti G.K.; Saini S.; Singh B.; Anti-Alzheimer\u2019s potential of berberine using surface decorated multi-walled carbon nanotubes: A preclinical evidence. Int J P\u2019Ceutics 2017,530(1-2),263-278","journal-title":"Int J P\u2019Ceutics"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.biopha.2017.11.047","volume":"97","author":"Kheradmand E.","year":"2018","unstructured":"Kheradmand E.; Hajizadeh Moghaddam A.; Zare M.; Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer\u2019s disease. Biomed Pharmacother 2018,97,1096-1101","journal-title":"Biomed Pharmacother"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-2005-7405","volume":"7","author":"Shea T.B.","year":"2005","unstructured":"Shea T.B.; Ortiz D.; Nicolosi R.J.; Kumar R.; Watterson A.C.; Nanosphere-mediated delivery of vitamin E increases its efficacy against oxidative stress resulting from exposure to amyloid beta. J Alzheimers Dis 2005,7(4),297-301","journal-title":"J Alzheimers Dis"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2013.03.022","volume":"66","author":"Niki E.","year":"2014","unstructured":"Niki E.; Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med 2014,66,3-12","journal-title":"Free Radic Biol Med"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"10906","DOI":"10.1016\/S0021-9258(18)82071-3","volume":"268","author":"Constantinescu A.","year":"1993","unstructured":"Constantinescu A.; Han D.; Packer L.; Vitamin E recycling in human erythrocyte membranes. J Biol Chem 1993,268(15),10906-10913","journal-title":"J Biol Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2147\/CIA.S186760","volume":"14","author":"Browne D.","year":"2019","unstructured":"Browne D.; McGuinness B.; Woodside J.V.; McKay G.J.; Vitamin E and Alzheimer\u2019s disease: what do we know so far? Clin Interv Aging 2019,14,1303-1317","journal-title":"Clin Interv Aging"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.npep.2016.03.002","volume":"58","author":"Vedagiri A.","year":"2016","unstructured":"Vedagiri A.; Thangarajan S.; Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid \u03b225-35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer\u2019s disease. Neuropeptides 2016,58,111-125","journal-title":"Neuropeptides"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.actbio.2015.06.035","volume":"25","author":"Yin T.","year":"2015","unstructured":"Yin T.; Yang L.; Liu Y.; Zhou X.; Sun J.; Liu J.; Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer\u2019s disease. Acta Biomater 2015,25,172-183","journal-title":"Acta Biomater"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1039\/C5TB00731C","volume":"3","author":"Zhou X.","year":"2015","unstructured":"Zhou X.; Sun J.; Yin T.; Le F.; Yang L.; Liu Y.; Liu J.; Enantiomers of cysteine-modified SeNPs (d\/lSeNPs) as inhibitors of metal-induced A\u03b2 aggregation in Alzheimer\u2019s disease. J Mater Chem B Mater Biol Med 2015,3(39),7764-7774","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1872211312666171207152326","volume":"12","author":"Koynova R.","year":"2018","unstructured":"Koynova R.; Tenchov B.; Natural product formulations for the prevention and treatment of Alzheimer\u2019s disease: A patent review. Recent Pat Drug Deliv Formul 2018,12(1),23-39","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=130","first-page":"1","author":"Madhu S.","year":"2021","unstructured":"Madhu S.; Komala M.; Pandian P.; Formulation development and characterization of withaferin-A loaded polymeric nanoparticles for Alzheimer\u2019s disease. Bio Nano Sci 2021,1-8","journal-title":"Bio Nano Sci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/YCO.0000000000000310","volume":"30","author":"Ansari S.A.","year":"2017","unstructured":"Ansari S.A.; Satar R.; Perveen A.; Ashraf G.M.; Current opinion in Alzheimer\u2019s disease therapy by nanotechnology-based approaches. Curr Opin Psychol 2017,30(2),128-135","journal-title":"Curr Opin Psychol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.2147\/IJN.S183117","volume":"13","author":"Ross C.","year":"2018","unstructured":"Ross C.; Taylor M.; Fullwood N.; Allsop D.; Liposome delivery systems for the treatment of Alzheimer\u2019s disease. Int J Nanomed 2018,13,8507-8522","journal-title":"Int J Nanomed"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/jphp.13132","volume":"71","author":"Harilal S.","year":"2019","unstructured":"Harilal S.; Jose J.; Parambi D.G.T.; Kumar R.; Mathew G.E.; Uddin M.S.; Kim H.; Mathew B.; Advancements in nanotherapeutics for Alzheimer\u2019s disease: current perspectives. J Pharm Pharmacol 2019,71(9),1370-1383","journal-title":"J Pharm Pharmacol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fbioe.2020.00238","volume":"8","author":"Moradi S.Z.","year":"2020","unstructured":"Moradi S.Z.; Momtaz S.; Bayrami Z.; Farzaei M.H.; Abdollahi M.; Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front Bioeng Biotechnol 2020,8,238","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s13346-019-00694-3","volume":"10","author":"Ramalho M.J.","year":"2020","unstructured":"Ramalho M.J.; Andrade S.; Loureiro J.A.; do Carmo Pereira M.; Nanotechnology to improve the Alzheimer\u2019s disease therapy with natural compounds. Drug Deliv Transl Res 2020,10(2),380-402","journal-title":"Drug Deliv Transl Res"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666211015152733","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197271\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666211015152733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:51:37Z","timestamp":1671274297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197271\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201818666211015152733","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}